Neuronal release of vasoactive intestinal peptide is important to astrocytic protection of neurons from glutamate toxicity

Molecular and Cellular Neurosciences

Volumn 15, Issue 5, 2000, Pages 465-475

  Brown, David R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; INTERLEUKIN 6; RNA; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; COCULTURE; CONTROLLED STUDY; MOUSE; NERVE CELL; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

EID: 0034121133     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2000.0840     Document Type: Article

References (40)

1. Ashur-Fabian O., Giladi E., Brenneman D. E., Gozes I. Identification of VIP/PACAP receptors on rat astrocytes using antisense oligonucleotides. J. Mol. Neurosci. 9:1998;211-222.
2. Bassan M., Zamostiano R., Giladi E., Davidson A., Wollman Y., Pitman J., Hauser J., Brenneman D. E., Gozes I. The identification of secreted heat shock 60-like protein from rat glial cells and a human neuroblastoma cell line. Neurosci. Lett. 250:1998;37-40.
3. Bassan M., Zamostiano R., Davidson A., Pinhasov A., Giladi E., Perl O., Bassan H., Blat C., Gibney G., Glazner G., Brenneman D. E., Gozes I. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J. Neurochem. 72:1999;1283-1293.
4. Bondy S. L. C., Lee D. K. Oxidative stress induced by glutamate receptor agonists. Brain Res. 610:1993;229-233.
5. Brenneman D. E., Eiden L. E. Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl. Acad. Sci. USA. 83:1986;1159-1162.
6. Brenneman D. E., Nicol T., Warren D., Bowels L. M. Vasoactive intestinal peptide: A neurotrophic releasing agent and an astroglial mitogen. J. Neurosci. Res. 25:1990;386-394.
7. Brenneman D. E., Gozes I. A femtomolar-acting neuroprotective peptide. J. Clin. Invest. 97:1996;2299-2307.
8. Brown D. R. Neurons depend on astrocytes in a coculture system for protection from glutamate toxicity. Mol. Cell. Neurosci. 13:1999a;379-389.
9. Brown D. R. Dependence of neurones on astrocytes in a co-culture system renders neurones sensitive to TGF-β1 induced glutamate toxicity. J. Neurochem. 72:1999b;943-953.
10. Brown D. R., Schmidt B., Kretzschmar H. A. A neurotoxic prion protein fragment enhances proliferation of microglia but not astrocytes in culture. Glia. 18:1996a;59-67.
11. Brown D. R., Schmidt B., Kretzschmar H. A. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature. 380:1996b;345-347.
12. Brown D. R., Mohn C. M. Astrocytic glutamate uptake and prion protein expression. Glia. 25:1999;282-292.
13. Choi D. W., Koh J.-Y., Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: Attenuation by NMDA antagonists. J. Neurosci. 8:1988;185-196.
14. Cholewinski A. J., Wilkin G. P. Astrocytes from forebrain, cerebellum, and spinal cord differ in their responses to vasoactive intestinal peptide. J. Neurochem. 51:1988;1626-1633.
15. Fatatis A., Holtzcaw L. A., Avidor R., Brenneman D. E., Russel J. T. Vasoactive intestinal peptide increases intracellular calcium in astroglia: Synergism with α-adrenergic receptors. Proc. Natl. Acad. Sci. USA. 91:1994;2036-2040.
16. Gallo V., Ciotti M. T., Coletti A., Aloisi F., Levi G. Selective release of glutamate from cerebellar granule cells differentiating in culture. Proc. Natl. Acad. Sci. USA. 79:1982;7919-7923.
17. Gottschall P. E., Tatsuno I., Arimura A. Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: Synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating peptide (PACAP). Brain Res. 637:1994;197-203.
18. Gozes I., McCune S. K., Jacobson L., Warren D., Moody T. W., Fridkin M., Benneman D. E. An antagonist to vasoactive intestinal peptide: Effect on cellular function in the central nervous system. J. Pharmacol. Exp. Ther. 257:1991;959-966.
19. Gurantz D., Harootunian A. T., Tsien R. Y., Dionne V. E., Margiotta J. M. VIP modulates neuronal nicotinic acetylcholine receptor function by a cyclic AMP dependent mechanism. J. Neurosci. 14:1994;3540-3547.
20. +-dependent glutamate uptake in rat hippocampal astrocyte cultures. J. Neurochem. 67:1996;277-286.
21. Huang R., Shuaib A., Hertz L. Glutamate uptake and glutamate content in primary cultures of mouse astrocytes during anoxia, substrate deprivation and simulated ischemia under normothermic and hypothermic conditions. Brain Res. 618:1993;346-351.
22. Levy L. M., Lehre K. P., Walaas S. I., Storm-Mathisen J., Danbolt N. C. Down-regulation of glial glutamate transporters after glutamatergic denervation in the rat brain. Eur. J. Neurosci. 7:1995;2036-2041.
23. Martin J.-L., Magistretti P. J. Release of vasoactive intestinal peptide in mouse cerebral cortex: Evidence for a role for arachidonic acid and metabolites. J. Neurosci. 9:1989a;2536-2542.
24. + in mouse cerebral cortical slices. Neuroscience. 30:1989b;423-431.
25. 3H]glutamate in rat brain tissue. Brain Res. 115:1976;139-144.
26. Mo N., Dun N. J. Vasoactive intestinal polypeptide facilitates muscarinic transmission in mammalian sympathetic ganglia. Neurosci. Lett. 52:1984;19-23.
27. Pellegri G., Magistretti P. J., Martin J.-L. VIP and PACAP potentiate the action of glutamate on BDNF expression in mouse cortical neurones. Eur. J. Neurosci. 10:1998;272-280.
28. Robinson M. B., Djali S., Buchhalter J. R. Inhibition of glutamate uptake with l-trans-pyrolidine-2,4-dicarboxylate potentiates glutamate toxicity in primary hippocampal cultures. J. Neurochem. 61:1993;2099-2103.
29. Rosenberg P. A., Amin S., Leitner M. Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture. J. Neurosci. 12:1992;56-61.
30. Said S. I., Mutt V. Polypeptide with broad biological activity: Isolation from small intestine. Science. 169:1970;1217-1218.
31. Schinder A. F., Olson E. C., Spitzer N. C., Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16:1996;6125-6133.
32. Speliotes E. K., Hartnett K. A., Blitzblau R. C., Aizenman E., Rosenberg P. A. Comparison of the potency of competitive NMDA antagonists against the neurotoxicity of glutamate and NMDA. J. Neurochem. 63:1994;879-885.
33. Swanson R. A. Astrocyte glutamate uptake during chemical hypoxia in vitro. Neurosci. Lett. 147:1992;143-146.
34. Vandenberghe W., Van Den Bosch L., Robberecht W. Glial cells potentiate kainate-induced neuronal death in a motoneuron-enriched spinal coculture system. Brian Res. 807:1998;1-10.
35. Volterra A., Trotti D., Cassutti P., Tromba C., Salvaggio A., Melcangi R. C., Racagni G. High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes. J. Neurochem. 59:1992;600-606.
36. Volterra A., Trotti D., Racagni G. Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms. Mol. Pharmacol. 46:1994a;986-992.
37. Volterra A., Trotti D., Tromba C., Floridi S., Racagni G. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14:1994b;2924-2932.
38. Westergaard N., Fosmark H., Schousboe A. Metabolism and release of glutamate in cerebellar granule cells cocultured with astrocytes from cerebellum and cortex. J. Neurochem. 56:1991;59-66.
39. Willard A. L. A vasoactive intestinal peptide-like cotransmitter at cholinergic synapses between rat mesenteric neurons in cell culture. J. Neurosci. 10:1990;1025-1034.
40. Ye Z.-C., Sontheimer H. Astrocytes protect neurones from neurotoxic injury by serum glutamate. Glia. 22:1998;237-248.